100.17 USD
▲-0.53+4.26%
盘后 95.97 -0.11%
2026-08-03
市值
—
规模 AUM
$84.21M
EPS
—
股息率
—
52 周区间
49.24 – 110.25
成交量
5.67K
Beta
1.19
目标价
—
52W 低 49.2452W 高 110.25
价格走势
公司简介
The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.